Excelsyn Mulls Technology Backlog Spin-Off

Excelsyn (Holywell, U.K.), a custom synthesis firm, may spin off a backlog of six fields of intellectual property (IP) into a separate company, CW has learned. The IP relates to four distinct areas of biotransformation technology and two organometallic catalyst technologies. Shott: May approach venture capital firms. Excelsyn does not currently have access to enough capital to fully exploit the technology backlog and a spin-off appears to be the best course of action, Excelsyn managing director and founder Ian Shott says. Excelsyn will consider options during the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers